The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
Indian River County recorded the highest rate of new cases on the Treasure Coast, with 14 per 100,000 people diagnosed with ...
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
Researchers in the TB Alliance informed the Union Conference on Lung Health in Copenhagen that Sorbequiline, a new antibiotic ...
AllAfrica on MSN
Uganda Aids Commission Calls for Stronger Community Action As Country Begins Countdown to Ending Aids By 2030
As Uganda prepares to commemorate World AIDS Day 2025, the Uganda AIDS Commission (UAC) has called for renewed commitment, deeper community engagement, and accelerated action to end AIDS as a public ...
THERE’S been an “alarming” increase in HIV infections among straight women, a new report warns. It comes as sexual health ...
Gilead Sciences, Inc. today announced the delivery of first shipments of lenacapavir ? Gilead's twice-yearly injectable HIV-1 capsid inhibitor ? for the prevention of HIV as pre-exposure prophylaxis ...
Gilead Sciences has announced positive topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the treatment responses of adults with HIV who ...
Limako currently serves as a board member at EK FM, where she utilises radio to promote disability awareness and inclusion. She is also the disability coordinator for Positive Convention, promoting ...
How the efficacy of Virodene was finally put to the test, and why the war on anti-retrovirals ended The previous article documented how Deputy President Thabo Mbeki and Health Minister Nkosazana Zuma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback